Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'JOYCE JN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Joyce, JN; Ryoo, H; Gurevich, EV; Adler, C; Beach, T
      Ventral striatal D-3 receptors and Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    2. Gurevich, EV; Robertson, RT; Joyce, JN
      Thalamo-cortical afferents control transient expression of the dopamine D-3 receptor in the rat somatosensory cortex

      CEREBRAL CORTEX
    3. Joyce, JN
      D-2 but not D-3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period

      SYNAPSE
    4. Joyce, JN
      Dopamine D-3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

      PHARMACOLOGY & THERAPEUTICS
    5. Joyce, JN; Yoshimoto, K; Ueda, S
      The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system

      NEUROREPORT
    6. Gurevich, EV; Kordower, JH; Joyce, JN
      Ontogeny of the dopamine D-2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex

      JOURNAL OF CHEMICAL NEUROANATOMY
    7. Gurevich, EV; Joyce, JN
      Dopamine D-3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat

      JOURNAL OF COMPARATIVE NEUROLOGY
    8. GUREVICH EV; JOYCE JN
      DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS

      Neuropsychopharmacology
    9. Neal-Beliveau, BS; Joyce, JN
      Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions

      NEUROTOXICOLOGY AND TERATOLOGY
    10. Gurevich, EV; Himes, JW; Joyce, JN
      Developmental regulation of expression of the D-3 dopamine receptor in ratnucleus accumbens and Islands of Calleja

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    11. Ma, SY; Ciliax, BJ; Stebbins, G; Jaffar, S; Joyce, JN; Cochran, EJ; Kordower, JH; Mash, DC; Levey, AI; Mufson, EJ
      Dopamine transporter-immunoreactive neurons decrease with age in the humansubstantia nigra

      JOURNAL OF COMPARATIVE NEUROLOGY
    12. JOYCE JN; MURRAY AM; HURTIG HI; GOTTLIEB GL; TROJANOWSKI JQ
      LOSS OF DOPAMINE D-2 RECEPTORS IN ALZHEIMERS-DISEASE WITH PARKINSONISM BUT NOT PARKINSONS OR ALZHEIMERS-DISEASE

      Neuropsychopharmacology
    13. RYOO HL; PIERROTTI D; JOYCE JN
      DOPAMINE D-3 RECEPTOR IS DECREASED AND D-2 RECEPTOR IS ELEVATED IN THE STRIATUM OF PARKINSONS-DISEASE

      Movement disorders
    14. RIOUX L; NISSANOV J; JOYCE JN
      INCREASED NUMBER OF [I-125] BH-SUBSTANCE-P RECEPTORS IN SCHIZOPHRENIA

      Progress in neuro-psychopharmacology & biological psychiatry
    15. THOMAS WS; NEALBELIVEAU BS; JOYCE JN
      THERE IS A LIMITED CRITICAL PERIOD FOR DOPAMINES EFFECTS ON D1 RECEPTOR EXPRESSION IN THE DEVELOPING RAT NEOSTRIATUM

      Developmental brain research
    16. NEALBELIVEAU BS; JOYCE JN
      BEHAVIORAL RESPONSITIVITY TO DOPAMINE-RECEPTOR AGONISTS AFTER EXTENSIVE STRIATAL DOPAMINE LESIONS DURING DEVELOPMENT

      Developmental psychobiology
    17. JOYCE JN; MYERS AJ; GUREVICH E
      DOPAMINE D2 RECEPTOR BANDS IN NORMAL HUMAN TEMPORAL CORTEX ARE ABSENTIN ALZHEIMERS-DISEASE

      Brain research
    18. GUREVICH EV; KORDOWER J; JOYCE JN
      DOPAMINE D2 RECEPTOR MESSENGER-RNA IS EXPRESSED IN MATURING NEURONS OF THE HUMAN HIPPOCAMPAL AND SUBICULAR FIELDS

      NeuroReport
    19. JOYCE JN; GUREVICH EV
      CORTEX AND SEROTONIN IN SCHIZOPHRENIA - EFFECTS OF ANTIPSYCHOTIC TREATMENT

      Schizophrenia research
    20. GUREVICH EV; JOYCE JN
      DOPAMINE D2 RECEPTOR MESSENGER-RNA EXPRESSION IN THE HIPPOCAMPAL-FORMATION OF SCHIZOPHRENICS

      Schizophrenia research
    21. JOYCE JN; MEADORWOODRUFF JH
      LINKING THE FAMILY OF D-2 RECEPTORS TO NEURONAL CIRCUITS IN HUMAN BRAIN - INSIGHTS INTO SCHIZOPHRENIA

      Neuropsychopharmacology
    22. FROHNA PA; NEALBELIVEAU BS; JOYCE JN
      DELAYED PLASTICITY OF THE MESOLIMBIC DOPAMINE SYSTEM FOLLOWING NEONATAL 6-OHDA LESIONS

      Synapse
    23. JOYCE JN; SMUTZER G; WHITTY CJ; MYERS A; BANNON MJ
      DIFFERENTIAL MODIFICATION OF DOPAMINE TRANSPORTER AND TYROSINE-HYDROXYLASE MESSENGER-RNAS IN MIDBRAIN OF SUBJECTS WITH PARKINSONS, ALZHEIMERS WITH PARKINSONISM, AND ALZHEIMERS-DISEASE

      Movement disorders
    24. RIOUX L; FROHNA PA; JOYCE JN; SCHNEIDER JS
      THE EFFECTS OF CHRONIC LEVODOPA TREATMENT ON PRESYNAPTIC AND POSTSYNAPTIC MARKERS OF DOPAMINERGIC FUNCTION IN STRIATUM OF PARKINSONIAN MONKEYS

      Movement disorders
    25. JOYCE JN; RYOO HL
      DOPAMINE D3 RECEPTOR IS DECREASED AND D2 RECEPTOR IS UNCHANGED IN THEFOREBRAIN OF PATIENTS WITH PARKINSONS-DISEASE

      Annals of neurology
    26. JOYCE JN; GOLDSMITH SG; GUREVICH EV
      LIMBIC CIRCUITS AND MONOAMINE RECEPTORS - DISSECTING THE EFFECTS OF ANTIPSYCHOTICS FROM DISEASE PROCESSES

      Journal of Psychiatric Research
    27. GUREVICH EV; JOYCE JN
      ALTERATIONS IN THE CORTICAL SEROTONERGIC SYSTEM IN SCHIZOPHRENIA - A POSTMORTEM STUDY

      Biological psychiatry
    28. JOYCE JN; GUREVICH EV
      ANATOMY OF D2 AND D3 RECEPTOR NEURONS IN THE HUMAN MEDIAL TEMPORAL-LOBE

      Biological psychiatry
    29. GOLDSMITH SK; SHAPIRO RM; JOYCE JN
      DISRUPTED PATTERN OF D-2 DOPAMINE-RECEPTORS IN THE TEMPORAL-LOBE IN SCHIZOPHRENIA - A POSTMORTEM STUDY

      Archives of general psychiatry
    30. GUREVICH EV; BORDELON Y; SHAPIRO RM; ARNOLD SE; GUR RE; JOYCE JN
      MESOLIMBIC DOPAMINE D-3 RECEPTORS AND USE OF ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA - A POSTMORTEM STUDY

      Archives of general psychiatry
    31. GUREVICH EV; JOYCE JN
      COMPARISON OF [H-3] PAROXETINE AND [H-3] CYANOIMIPRAMINE FOR QUANTITATIVE MEASUREMENT OF SEROTONIN TRANSPORTER SITES IN HUMAN BRAIN

      Neuropsychopharmacology
    32. GOLDSMITH SK; JOYCE JN
      DOPAMINE D2 RECEPTORS ARE ORGANIZED IN BANDS IN NORMAL HUMAN TEMPORALCORTEX

      Neuroscience
    33. JOYCE JN; FROHNA PA; NEALBELIVEAU BS
      FUNCTIONAL AND MOLECULAR DIFFERENTIATION OF THE DOPAMINE SYSTEM INDUCED BY NEONATAL DENERVATION

      Neuroscience and biobehavioral reviews
    34. SOLBRIG MV; KOOB GF; JOYCE JN; LIPKIN WI
      A NEURAL SUBSTRATE OF HYPERACTIVITY IN BORNA-DISEASE - CHANGES IN BRAIN DOPAMINE-RECEPTORS

      Virology
    35. GUREVICH EV; JOYCE JN
      [I-125] RTI-55 BINDING TO THE SEROTONIN TRANSPORTER, [I-125] LSD BINDING TO 5-HT2 AND [H-3] 8-OH-DIPAT BINDING TO 5-HT1A RECEPTORS IN SCHIZOPHRENIC PREFRONTAL CORTEX

      Schizophrenia research
    36. JOYCE JN; GUREVICH EV; KUNG HF; KUNG MP; BORDELON Y; SHAPIRO R; ARNOLD SE; GUR RE
      DOPAMINE D3 RECEPTORS ARE ELEVATED IN SCHIZOPHRENIC BRAIN AND DECREASED BY NEUROLEPTIC TREATMENT

      Schizophrenia research
    37. FROHNA PA; ROTHBLAT DS; JOYCE JN; SCHNEIDER JS
      ALTERATIONS IN DOPAMINE UPTAKE SITES AND D1 AND D2 RECEPTORS IN CATS SYMPTOMATIC FOR AND RECOVERED FROM EXPERIMENTAL PARKINSONISM

      Synapse
    38. MURRAY AM; WEIHMUELLER FB; MARSHALL JF; HURTIG HI; GOTTLEIB GL; JOYCE JN
      DAMAGE TO DOPAMINE SYSTEMS DIFFERS BETWEEN PARKINSONS-DISEASE AND ALZHEIMERS-DISEASE WITH PARKINSONISM

      Annals of neurology
    39. FROHNA PA; NEALBELIVEAU BS; JOYCE JN
      NEONATAL 6-HYDROXYDOPAMINE LESIONS LEAD TO OPPOSING CHANGES IN THE LEVELS OF DOPAMINE-RECEPTORS AND THEIR MESSENGER-RNAS

      Neuroscience
    40. JOYCE JN; FROHNA P
      PARTIAL STRIATAL DA LOSS IN NEONATE PRODUCES IMMEDIATE AND LONG-TERM LOSS OF D1 RECEPTORS BUT ELEVATED MESSENGER-RNA

      Developmental psychobiology
    41. NEALBELIVEAU BS; YANKE B; JOYCE JN
      NEONATAL STRIATAL DOPAMINE LESIONS - BEHAVIORAL-EFFECTS ARE DEPENDENTUPON DEGREE OF DEPLETION

      Developmental psychobiology
    42. GOLDSMITH SK; JOYCE JN
      ALTERATIONS IN HIPPOCAMPAL MOSSY FIBER PATHWAY IN SCHIZOPHRENIA AND ALZHEIMERS-DISEASE

      Biological psychiatry
    43. GOLDSMITH SK; JOYCE JN
      DOPAMINE D2 RECEPTOR EXPRESSION IN HIPPOCAMPUS AND PARAHIPPOCAMPAL CORTEX OF RAT, CAT, AND HUMAN IN RELATION TO TYROSINE HYDROXYLASE-IMMUNOREACTIVE FIBERS

      Hippocampus
    44. JOYCE JN
      ON AGE AND SEROTONIN RECEPTOR-BINDING IN THE HUMAN BRAIN - REPLY

      Neuropsychopharmacology
    45. LEXOW N; JOYCE JN; KIM SJ; PHILLIPS J; CASANOVA MF; BIRD ED; KLEINMAN JE; WINOKUR A
      ALTERATIONS IN TRH RECEPTORS IN TEMPORAL-LOBE OF SCHIZOPHRENICS - A QUANTITATIVE AUTORADIOGRAPHIC STUDY

      Synapse
    46. ULAS J; WEIHMULLER FB; BRUNNER LC; JOYCE JN; MARSHALL JF; COLMAN CW
      SELECTIVE INCREASE OF NMDA-SENSITIVE GLUTAMATE BINDING IN THE STRIATUM OF PARKINSONS-DISEASE, ALZHEIMERS-DISEASE, AND MIXED PARKINSONS-DISEASE ALZHEIMERS-DISEASE PATIENTS - AN AUTORADIOGRAPHIC STUDY

      The Journal of neuroscience
    47. MURRAY AM; RYOO HL; GUREVICH E; JOYCE JN
      LOCALIZATION OF DOPAMINE D-3 RECEPTORS TO MESOLIMBIC AND D-2 RECEPTORS TO MESOSTRIATAL REGIONS OF HUMAN FOREBRAIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    48. RYOO HL; JOYCE JN
      LOSS OF DOPAMINE D2 RECEPTORS VARIES ALONG THE ROSTROCAUDAL AXIS OF THE HIPPOCAMPAL COMPLEX IN ALZHEIMERS-DISEASE

      Journal of comparative neurology
    49. FROHNA PA; JOYCE JN
      DEVELOPMENTAL PLASTICITY OF THE DOPAMINE SYSTEMS IN THE RODENT BASAL GANGLIA

      Biological psychiatry
    50. GUREVICH EV; KUNG MP; BORDELON Y; JOYCE JN
      MESOLIMBIC DOPAMINE D3 RECEPTORS - ELEVATION IN SCHIZOPHRENICS

      Biological psychiatry
    51. JOYCE JN; GUREVICH EV
      [H-3] PAROXETINE BINDING IN HUMAN BRAIN - COMPARISON WITH [H-3] CYANOIMIPRAMINE

      Biological psychiatry
    52. FROHNA PA; NEALBELIVEAU BS; JOYCE JN
      NEONATAL 6-OHDA LESIONS UP-REGULATE ADULT EXPRESSION OF TYROSINE-HYDROXYLASE MESSENGER-RNA

      NeuroReport
    53. RIOUX L; JOYCE JN
      SUBSTANCE-P RECEPTORS ARE DIFFERENTIALLY AFFECTED IN PARKINSONS AND ALZHEIMERS-DISEASE

      Journal of neural transmission. Parkinson's disease and dementia section
    54. JOYCE JN; SHANE A; LEXOW N; WINOKUR A; CASANOVA MF; KLEINMAN JE
      SEROTONIN UPTAKE SITES AND SEROTONIN RECEPTORS ARE ALTERED IN THE LIMBIC SYSTEM OF SCHIZOPHRENICS

      Neuropsychopharmacology
    55. NEALBELIVEAU BS; JOYCE JN
      D(1) AND D(2) DOPAMINE-RECEPTORS DO NOT UP-REGULATE IN RESPONSE TO NEONATAL INTRASTRIATAL 6-HYDROXYDOPAMINE LESIONS

      Neuroscience letters
    56. JOYCE JN; KAEGER C; RYOO H; GOLDSMITH S
      DOPAMINE D2 RECEPTORS IN THE HIPPOCAMPUS AND AMYGDALA IN ALZHEIMERS-DISEASE

      Neuroscience letters
    57. NEALBELIVEAU BS; JOYCE JN; LUCKI I
      SEROTONERGIC INVOLVEMENT IN HALOPERIDOL-INDUCED CATALEPSY

      The Journal of pharmacology and experimental therapeutics
    58. JOYCE JN
      THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - LIMBIC INTERACTIONS WITH SEROTONIN AND NOREPINEPHRINE

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 15:21:33